Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure

<div>Morphological changes of ovarian tissue (HE staining: 200X). (a) Model group, (b) MTHSWD low-dose group, (c) MTHSWD medium-dose group, (d) MTHSWD high-dose group, (e) positive control group, and (f) blank group. O: oocyte, FL: follicular fluid, FF: follicular cavity, GC: granular cell, ZP: zona pellucida, Cap: blood vessel, and black arrow points to white blood cell.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure 

Figure 9 | Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure 